Literature DB >> 4015461

A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China.

S C Li, B S Schoenberg, C C Wang, X M Cheng, D Y Rui, C L Bolis, D G Schoenberg.   

Abstract

A door-to-door survey was conducted in six cities of the People's Republic of China. A total of 63,195 individuals were sampled during 1983 to determine the prevalence of major neurologic disorders. The survey involved a complete census, followed by a pretested interview and brief screening examination with a high level of sensitivity for detecting individuals with frequently occurring neurologic diseases, including movement disorders. Subjects with abnormal responses or findings were examined by a neurologist. There was 100% cooperation among the study subjects. Twenty-eight individuals alive on prevalence day (Jan 1, 1983) were identified as having Parkinson's disease, yielding an age-adjusted (to the 1960 US population) prevalence ratio of 57 per 100,000 population. All subjects were older than the age of 50 years. After the fifth decade of life, the age-specific prevalence ratios increased with age.

Entities:  

Mesh:

Year:  1985        PMID: 4015461     DOI: 10.1001/archneur.1985.04060070045013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  37 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

Review 2.  Screening questionnaires for parkinsonism: a systematic review.

Authors:  Nabila Dahodwala; Andrew Siderowf; Mona Baumgarten; Aaron Abrams; Jason Karlawish
Journal:  Parkinsonism Relat Disord       Date:  2011-09-17       Impact factor: 4.891

3.  Parkinson's disease in China.

Authors:  You-yong Tian; Cui-ju Tang; Jie Wu; Jun-shan Zhou
Journal:  Neurol Sci       Date:  2010-12-14       Impact factor: 3.307

4.  Clinical characteristics of essential tremor in Mersin, Turkey--a population-based door-to-door study.

Authors:  Okan Dogu; Elan D Louis; Serhan Sevim; Hakan Kaleagasi; Mihriban Aral
Journal:  J Neurol       Date:  2005-03-22       Impact factor: 4.849

Review 5.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

6.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

Authors:  M C de Rijk; C Tzourio; M M Breteler; J F Dartigues; L Amaducci; S Lopez-Pousa; J M Manubens-Bertran; A Alpérovitch; W A Rocca
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

7.  Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.

Authors:  Hae-Won Shin; Jae Seung Kim; Minyoung Oh; Sooyeoun You; Young Jin Kim; Juyeon Kim; Mi-Jung Kim; Sun Ju Chung
Journal:  Neurol Sci       Date:  2014-09-18       Impact factor: 3.307

8.  Nigrostriatal neuronal death following chronic dichlorvos exposure: crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changes.

Authors:  B K Binukumar; Amanjit Bal; Ramesh J L Kandimalla; Kiran Dip Gill
Journal:  Mol Brain       Date:  2010-11-13       Impact factor: 4.041

9.  Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.

Authors:  Nancy Bélanger; Laurent Grégoire; Paul Bédard; Thérèse Di Paolo
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 10.  Estrogens and Parkinson disease: novel approach for neuroprotection.

Authors:  Hideyuki Sawada; Shun Shimohama
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.